NAD+ injection costs: compare the amount, the form and the care

Start with what the advertised unit means

A quote of so much per shot sounds easy to compare until another clinic quotes a vial and a third quotes an infusion visit. The first may describe an administration, the second a container and the third an appointment. None automatically tells you the total amount supplied, the length of the financial commitment or the cost of follow-up. Put the purchase into words before reducing it to a number: which preparation, which route, how much product, which services and when the next payment is due.

This guide adds quantity comparisons to our complete care quote framework. It does not publish a market-average NAD+ price or estimate what a patient should receive. A provider menu with an introductory amount but no renewal figure cannot support an ongoing-cost estimate. Leave that missing amount visible. A precise division performed on incomplete terms still produces an incomplete comparison.

Read milligrams, milliliters and concentration separately

Milligrams describe mass. Milliliters describe volume. A concentration written in mg/mL describes mass per volume, so the filled volume is needed to calculate the total stated mass in a liquid container. A label showing concentration alone does not tell you how much is being sold. A large vial photograph does not establish its filled volume either. Ask for the actual preparation description rather than estimating from packaging or a promotional image.

For purchase comparison only, imagine a liquid product described as 100 mg/mL with a filled volume of 5 mL. Multiplying 100 by 5 gives 500 mg of stated total content. A second product described as 200 mg/mL with 2.5 mL also contains a stated 500 mg. Their concentrations differ, while the total labeled amount in this example is equal. These invented descriptions are arithmetic examples, with no implication that either is an appropriate preparation or prescription.

Do not convert those figures into syringe marks, administration volumes or a treatment schedule. Those are different questions requiring the actual prescription and pharmacy instructions. Even an accurate description of labeled content does not independently verify its measured potency. Our NAD+ testing guide explains why a claim about concentration, a laboratory result and a claim about sterility need to be read separately.

Compare two fictional vial purchases

Suppose a fictional Quote A supplies a stated 500 mg for $150 in medication charges, while Quote B supplies a stated 1,000 mg for $240. On medication alone, A is $150 divided by 500, or $0.30 per stated milligram; B is $240 divided by 1,000, or $0.24. B has the lower amount per stated milligram and the higher immediate medication bill. Neither result tells you whether a larger purchase is useful, appropriate or usable within the pharmacy’s instructions.

Adding the fictional care fees changes both ratios: $210 divided by 500 is $0.42, and $280 divided by 1,000 is $0.28. The calculation assumes every listed charge applies to the same purchase period and that no other required charge is missing. If a consultation repeats on a different schedule, calculate its actual charges across the chosen comparison period first. Do not silently allocate one month of care against several months of product.

There is another limitation: the denominator describes purchased content, not necessarily content that will be used. Ask the pharmacy about labeled storage and use limits, and ask the provider how replacements are handled. Do not assume you can extend a supply indefinitely to improve the apparent price. Nor should you enlarge or change a prescribed amount to make a purchase look economical. A cheaper unused quantity can still mean a larger cash commitment.

Keep IV appointments and take-home products in separate comparisons

For an IV quote, ask whether the amount covers one appointment, a package of appointments or medication alone. Clarify whether the consultation, administration, monitoring, supplies and any mandatory additions are included. A hypothetical $300 session that explicitly supplies a stated 500 mg yields $0.60 per stated milligram for the entire session bill. That division mixes medication and service costs by design; label it as a session-cost ratio rather than treating it as a vial price.

Comparing that ratio with a take-home vial does not create a clinical equivalence. The route and service setting differ. The NAD+ IV evidence review discusses the separate research questions surrounding infusions, while our injection benefit review examines what human findings can support. Price arithmetic does not supply missing outcome evidence. A higher price also does not establish a more effective treatment.

Nasal sprays and creams need their own descriptions. For a spray, distinguish total bottle content from an explicitly stated amount per metered actuation; do not infer one from the other without the product specification. A cream may be described using a different concentration convention. Ask the pharmacist to clarify an unclear label instead of inventing a conversion. Our nasal spray review explains why evidence from another route cannot simply establish what a nasal preparation does.

Repeat the comparison for the renewal purchase

Build a second line for the next payable charge. Check whether the product quantity stays the same, whether a separate care fee increases and whether the billing period changes. If only an introductory medication figure is public, the renewal ratio is unknown. A recurring membership does not reveal the missing medication renewal price. Likewise, a printed monthly equivalent does not prove that the provider collects one payment each calendar month.

Use provider reviews to locate the unresolved questions before requesting that written quote. The Strut Health review and AgelessRx review give provider-specific context for a NAD+ comparison. The Eden review discusses a separate membership alongside longevity medication offers. A review link explains purchase terms; it does not establish that the product improves health or that an offer for another treatment covers NAD+. Confirm the terms for the exact preparation being considered.

Once you have the written charges, the care cost planner can combine the financial inputs you supply. Keep the separate quantity calculation beside it, with units written out. If the first charge covers an uncertain quantity, do not divide by an assumed amount. If the quantity is explicit but a mandatory fee is unknown, a medication-only ratio can be labeled as partial; the all-in ratio remains unresolved.

A low unit price cannot answer the quality question

FDA states that compounded drugs are not FDA-approved, and that the agency does not verify their safety, effectiveness or quality before marketing. ^[1] A quantity comparison cannot convert a compounded preparation into an approved product or establish its suitability. Identify the actual dispensing pharmacy and preparation rather than treating the telehealth brand as a complete description of the medicine.

FDA has also warned about food-grade NAD+ ingredients used for intravenous preparations without appropriate processing because of microbial and endotoxin contamination risks. ^[2] That warning is relevant to the questions to ask about sterile preparation; it does not establish a defect in every marketed vial or a numerical risk for a particular provider. A discount, a premium price and a purity percentage each leave different questions unanswered.

The useful comparison therefore has three conclusions, each with its own evidence: what you would pay, what stated quantity and services you would purchase, and what supports the proposed clinical use. Save the full quote and its conditions with your calculations. If a provider clarifies the renewal amount, revise the relevant line without changing the assumptions elsewhere. If the form or quantity changes, begin a new comparison. The result should remain understandable without relying on a promotional headline or a guessed treatment schedule.